<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="17705" whole_study_id="17705" phs="001038" v="1" p="1" createDate="2015-11-04T14:45:51-05:00" completedByGPADate="2015-11-04T14:56:22-05:00" modDate="2019-04-23T09:53:22-05:00" maxParentChildStudyModDate="2019-04-23T09:53:22-05:00" handle="DNA_MethylationInImmunotherapy" num_participants="18"><StudyInfo accession="phs001038.v1.p1" parentAccession="phs001038.v1.p1"><BioProject id="PRJNA305076" entrez_id="305076" type="bp_admin_access"/><BioProject id="PRJNA305077" entrez_id="305077" type="bp_data_submission"/><StudyNameEntrez>DNA Methylation Inhibitors in Immunotherapy</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_genome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="rna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>rna</StudyType><StudyType>whole_genome</StudyType><StudyType>rna_seq_derived_expression</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="CHANTMSKCC" aid="2" auth="eRA" login="CHANTMSKCC" fname="Timothy" mname="AN-THY" lname="Chan" email="chant2@ccf.org"><Role>PI</Role><Organization>CLEVELAND CLINIC FOUNDATIONSLOAN-KETTERING INST CAN RESEARCHCLEVELAND CLINIC LERNER COM-CWRU</Organization></Person><Person aid="8" auth="virtual" fname="Vladimir" lname="Makarov" email="makarovv@mskcc.org"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0010579723" aid="1" auth="cit" login="wewu" fname="Wenyu" mname="" lname="Wu" email="wwu@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001203526" aid="1" auth="cit" login="cagaananef" fname="Emilie" mname="Charlisse F" lname="Caga-Anan" email="charlisse.caga-anan@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>Research was supported by grants from The National Cancer Institute (NCI) CA058184 (S.B.B.), Stand Up To Cancer (SU2C) Epigenetic Dream Team (S.B.B.), the Hodson Trust (S.B.B.), the Samuel Waxman Cancer Research Foundation (S.B.B.), The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (S.B.B., D.J.S.), Department of Defense (DOD) Teal Award BC031272 (S.B.B.), the Pershing Square Sohn Cancer Research Alliance (T.A.C.), the STARR Cancer Consortium (T.A.C.), the Ludwig Foundation (J.D.W.), and NIH award F32CA183214 (K.B.C.), and German Cancer Aid (Deutsche Krebshilfe 108215) (R.S.). We acknowledge Mrs. Elizabeth Stiegler and Florentine Koppitz for their expert technical help and Kathy Bender for manuscript preparation. ABI TLDA qRT-PCR was conducted at the Genetic Resources Core Facility, Johns Hopkins Institute of Genetic Medicine, Baltimore, MD. We thank Ms. Jennifer Meyers and the Next Generation Sequencing Center at the Sidney Kimmel Comprehensive Cancer Center for Agilent Bioanalyzer analysis. D.M.P. is a consultant for Pfizer and Amplimmune. J.D.W. is a consultant for Bristol-Myers Squibb and receives research funding. S.B.B. consults for MDxHealth. Methylation-specific PCR (MSP) is licensed to MDxHealth in agreement with Johns Hopkins University (JHU), and S.B.B. and JHU are entitled to royalty shares received from sales.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="1792" CGType="cg_class_HMB" title="Health/Medical/Biomedical (PUB, NPU, MDS)" name="HMB-PUB-NPU-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>